An Operationally Seamless Phase 2/3 Randomized, Open-label, Multicenter, Active-Controlled Study to Evaluate the Safety and Efficacy of Bictegravir/Lenacapavir Versus Stable Baseline Regimen in Virologically Suppressed People With HIV-1 on Stable Complex Treatment Regimens

  • McMahon, James (Primary Chief Investigator (PCI))
  • Roney, Janine (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date30/03/23 → 1/05/25

Keywords

  • Clinical trial
  • HIV-1
  • Bictegravir
  • Lenacapavir